www.dnanexus.com 4 Strategies to Accelerate Precision Drug Discovery CHALLENGE To gain a deeper understanding of the molecular mechanisms of disease subphenotypes, research teams increasingly need the ability to leverage petabyte-scale datasets that combine multi-omics, imaging, and phenotypic data using a semantic backbone to facilitate advanced analytics, including machine learning and artificial intelligence. How can pharma leverage seamless data integration to effectively browse and mine untapped internal and external data sources? Large-scale omics datasets are revolutionizing how pharmaceutical companies identify targets for therapeutic development, and have become one of the main paths in accelerating precision medicine. For example, the DiscovEHR collabor

Join for free to read